Mechanically, these two mycotoxins activated caspase-9 and caspase-3, up-regulated Bax level, down-regulated bcl-2 level, and reduced MMP, thereby exhibiting anti-HCC activity. The gene discussed is CASP3; the disease is hepatocellular carcinoma.